Autolus Therapeutics plc - American Depositary Share (AUTL) Social Stream



Autolus Therapeutics plc - American Depositary Share (AUTL): $2.64

0.13 (+5.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AUTL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

AUTOLUS THERAPEUTICS PLC (AUTL) Price Targets From Analysts

Use the tables below to see what analysts covering AUTOLUS THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 6 $21 $7 $13.2 $2.3 473.91%
2021-12-20 5 $21 $7 $12.8 $2.3 456.52%
2022-03-31 6 $21 $7 $12.8 $2.3 456.52%
2022-05-06 6 $13 $7 $10.75 $2.3 367.39%
2022-05-16 5 $13 $7 $10.75 $2.3 367.39%
2022-08-05 5 $12 $7 $10.25 $2.3 345.65%
2022-08-18 6 $12 $7 $10.6 $2.3 360.87%
2022-11-04 6 $12 $7 $10.4 $2.3 352.17%

The Trend in the Analyst Price Target


Over the past 91 days, AUTL's average price target has gone up $0.15.

AUTL reports an average of 224.9% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-20 4 21 7 12.8 5.32 140.6%
2021-12-20 5 21 7 12.8 5.32 140.6%
2022-03-31 6 21 7 12.8 4.17 206.95%
2022-08-05 5 12 7 10.6 3.48 204.6%
2022-08-18 6 12 7 10.6 3.59 195.26%

AUTL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 4 1 1 0 0 6

The Trend in the Broker Recommendations


Over the past 92 days, AUTL's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • AUTOLUS THERAPEUTICS PLC's upside potential (average analyst target price relative to current price) is higher than 807.09% of all US stocks.
  • In the context of all US stocks, AUTOLUS THERAPEUTICS PLC's average analyst price target is greater than 116.78% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, AUTOLUS THERAPEUTICS PLC's variance in analysts' estimates is lower than -554.41% of them.
  • AUTOLUS THERAPEUTICS PLC's number of analysts covering the stock is greater than 607.38% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AUTOLUS THERAPEUTICS PLC are AVRO, MGTX, and SRRK.

Is AUTL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7742 seconds.